Resolvin D1 (RvD1) is an anti-inflammatory bioactive compound that can downregulate NF-κB inflammatory signals and inhibit renal cell apoptosis, highlighting its potential as a therapeutic target in septic AKI (Zhao et al., 2016). Here, NFKB1 is linked to acute kidney injury.